This page provides information for invited speakers, including abstract content, presentation content, and reimbursement for travel expenses. Invited speakers have been asked to present a named lecture, a plenary lecture, or a lecture for a workshop or symposium.
Abstract Content and Submission
Invited speaker abstracts should describe the talk with a state-of-the-art overview of the field or topic and not solely focused on the speaker’s own work. Invited speakers must submit their abstract and other information (current CV, photo, and permission to record) through the CROI Abstract Submission Portal.
Submission of other abstracts: Invited speakers may also submit general or late-breaking abstracts for presentation at CROI. The submission timeline can be found on the Important Dates page and submission instructions on the Abstract Submission page.
Presentation Length and Format
Allotted times and recommended number of slides for different invited speaker sessions:
- Plenary Presentations: 25 minutes each (25–30 slides)
- Symposia Presentations: 22 to 23 minutes each (20–25 slides) and 5 minutes for questions
- Workshop Presentations: 20 to 23 minutes* (20–23 slides) and 5 minutes for questions
*Presentation times for workshops may vary depending on the number of speakers
Requirements for Presentation Development
Presentations from randomized trials and cohorts should follow the International Committee of Medical Journal Editors (ICMJE) guidelines, including reporting of study designs, (eg, prospective, observational, randomized, double-blind, STROBE, CONSORT, or others), statistical methods, and outcomes by demographic variables. See the ICMJE guidelines for more details.
Appropriate information and correct terminology should be used with regard to sex and gender. For human clinical or epidemiological studies, sex-stratified results should be provided or who was included if it includes only a single population. Appropriate terminology such as cisgender (people whose gender match the sex assigned at birth) or transgender (people whose gender does not match the sex assigned at birth) should be used. Both sex and gender data should be provided in the presentation. Presentations of preclinical data including use of cell lines and animal studies should include the sex of the animals or the sex of the source of the cell lines. If data are not available on sex and gender, this should be identified as a limitation in your presentation.
Out of respect for their contributions to our scientific advances, avoid calling study volunteers “subjects.” The preferred terms are study “participants” or “volunteers.”
Please also note whether the study is ongoing or completed and whether the results are preliminary or final.
Title Slide with Financial Disclosures
CROI will provide a title slide with disclosure information for each presenter based on the information that was submitted with the abstract. Disclosure information includes all financial relationships with commercial entities (eg, pharmaceutical and diagnostic companies) as submitted by the presenter. If there are no financial relationships to report, the disclosure will read “Nothing to Disclose.” Below is a sample title slide provide to speakers by CROI:
Our experience indicates that speakers should allow 1 minute per slide. You may choose to use more than the recommended number of slides (see the Presentation Length and Format section), but please be sure to complete your presentation within the allocated time.
Please note that corporate logos, QR codes, and bar codes are not permitted on slides for oral presentations at CROI.
CROI will support MS PowerPoint or Apple Keynote only. Please ensure that all presentations are in one of these supported formats. High definition (HD) projectors will be used for all CROI sessions. Please apply widescreen formatting when preparing your slides (aspect ratio 16:9; resolution 1920 x 1080).
Speakers must bring their slides on a portable drive to the Speaker Ready Room so slides can be uploaded to the presentation computer. All presenters should bring their slides to the Speaker Ready Room at least 24 hours in advance of their presentation.
Invited Speaker Expenses
Invited Speakers receive the following support for their participation at CROI.
Waived registration fee: Registration fees are waived for lecturers in named presentations (Bernard Fields and N’Galy-Mann lecturers), Martin Delaney panelists, plenary speakers, symposium conveners, workshop conveners, symposium speakers, workshop presenters, and themed discussion leaders.
Travel expenses: Reimbursement for travel expenses is provided to named-presentation lecturers and panelists, plenary speakers, symposium speakers, workshop presenters, and themed discussion leaders. The maximum reimbursement is $1,800 for travel from within the US or from Canada and $2,750 for international travel. The following expenses may be reimbursed:
- Airfare (including fee for 1 checked bag), train fare, or auto miles
- Hotel accommodations
Reimbursement does not cover visa fees, ground transportation, parking, meals, incidental charges, printing or shipping of materials, office supplies, or internet access.
Invited speakers should book travel through the CROI travel agency, Altour, by completing an IAS-USA Airfare Request form. You may also contact Altour at 888-669-8291 (US) or via email at firstname.lastname@example.org for assistance.
The goods or services listed above are provided in kind for invited speaker participation in CROI. In compliance with federal regulations, no honorarium will be provided to US federal government employees, and no federal funds will be used for the payment of travel expenses. Travel expenses are derived from registration fees from conference attendees.
Please use one of the links below to access the appropriate expense report form. Note that the forms work best with Internet Explorer or Chrome. Instructions on how to complete and return the expense report appear on the form.
For reimbursement via wire transfer (available for travel from outside the US and Canada only) please complete the separate wire transfer form.